Related by context. All words. (Click for frequent words.) 74 CYT# potent vascular disrupting 72 IAP inhibitor 71 CYT# vascular disrupting 70 selective antagonist 70 receptor tyrosine kinase inhibitor 69 reversible inhibitor 69 dasatinib Sprycel ® 69 targeted radiotherapeutic 68 Panzem R 68 Alfacell proprietary ribonuclease 68 2 methoxyestradiol 67 highly selective inhibitor 67 R Saizen R 67 HMG CoA reductase inhibitors 67 small molecule tyrosine 67 ADP receptor antagonist 67 imatinib Gleevec ® 67 antiangiogenic agent 67 Pruvel TM 67 peripherally acting 67 THR beta agonist 67 mitogen activated ERK kinase 67 receptor partial agonist 67 investigational humanized monoclonal antibody 67 delta gamma agonist 67 DNA intercalator 67 neuro inflammatory 67 Phase 1b clinical trials 67 radiation sensitizer 66 XL# anticancer compounds 66 selective kinase inhibitor 66 kidney urologic 66 antimitotic 66 TLR8 agonist 66 Phase #b/#a clinical 66 CD8 + cytotoxic 66 Taxanes 66 irreversible inhibitor 66 Darinaparsin 66 polycythemia vera essential thrombocythemia 66 D aspartate NMDA receptor 66 proteasome inhibitors 66 Personalized Immunotherapy 66 treat chronic sinusitis 66 histone deacetylase inhibitor 66 candidates Azedra TM 66 erlotinib Tarceva ® 66 non thiazolidinedione TZD 66 orally administered inhibitor 66 hypoxia activated prodrug 66 sunitinib Sutent ® 66 liposome encapsulated 66 proteasome inhibitor 66 multi kinase inhibitor 66 histone deacetylase HDAC inhibitors 66 5 HT4 66 non nucleoside inhibitor 66 NS5B polymerase 66 TNF Tumor Necrosis Factor 66 signal transduction inhibitor 66 itraconazole Sporanox 66 cyclin dependent kinase inhibitor 66 Deforolimus 66 vinca alkaloid 66 IMiDs R 66 5 HT2A inverse 66 interferon beta 1a infertility 66 kinase inhibition 66 candidate deforolimus 66 ENMD # 65 CYP#A# CYP#D# 65 reversible inhibitors 65 liposomal formulation 65 vapreotide acetate 65 hypereosinophilic syndrome 65 myelofibrosis polycythemia vera 65 advanced metastatic renal 65 histone deacetylase HDAC inhibitor 65 Hsp# Inhibitor 65 tumors GIST 65 Vidofludimus 65 PNP inhibitor 65 AAG geldanamycin analog 65 novel VDA molecule 65 molecular imaging radiopharmaceutical 65 partial agonist 65 TOCOSOL Camptothecin 65 Bosutinib 65 secretory phospholipase A2 65 Aurora Kinase 65 Voreloxin 65 apoptosis inducer 65 novel topoisomerase 65 Pharmacokinetics PK 65 MKC# MT 65 AEG# 65 histone deacetylase HDAC 65 selective inverse agonist 65 sodium glucose cotransporter 65 apoptosis proteins 65 nilotinib Tasigna ® 65 induced mucositis 65 oral dual endothelin 65 selective adenosine 65 Sudhir Agrawal D.Phil 65 sphingosine 1 65 GW# [003] 65 drug zotarolimus 65 brand ciclesonide HFA 65 FOLFOX6 chemotherapy regimen 65 BCG refractory carcinoma 65 calcitonin gene related 65 protein kinase inhibitor 65 Peginterferon alfa 2b 65 tumor vascular disrupting 65 personalized immunotherapy 65 HCV NS5B polymerase 65 MTP inhibitor 65 EGFR tyrosine kinase inhibitor 65 demonstrated antitumor activity 65 triggers apoptosis programmed 65 chronic eosinophilic leukemia 64 Xanafide 64 small molecule chemotherapeutic 64 dopamine D2 64 M# rationally 64 Gleevec resistant 64 myelodysplastic myeloproliferative diseases 64 MAGE A3 ASCI 64 PEGylated Fab fragment 64 prostanoid 64 targeted antifolate 64 Daclizumab 64 Squalamine 64 XL# XL# 64 5 HT2A serotonin 64 SinuNase ™ 64 selectively inhibited 64 Imatinib mesylate 64 endothelin receptor antagonist DARA 64 mTOR mammalian target 64 oral prodrug 64 selective inhibitor 64 nucleoside analog 64 Factor Receptor 64 targets Galectin receptors 64 PI3K/mTOR 64 Xeloda ® 64 5 HT2A receptor 64 gastro intestinal inflammation 64 PI3 Kinase 64 topoisomerase II inhibitor 64 Annamycin 64 acetonide FA 64 Sphingosine 1 64 ATRA IV 64 alkylating agent 64 mu opioid receptor antagonist 64 accumulate preferentially 64 highly selective endothelin 64 polysaccharide polymer 64 Locked Nucleic Acid LNA 64 bladder ovarian 64 selective immunoproteasome inhibitor 64 potently inhibited 64 signal transduction inhibitors 64 hormone LHRH antagonist 64 HSP# inhibitor 64 PDE4 inhibitor 64 humanized monoclonal 64 KL4 Surfactant 64 developing Bicifadine serotonin 64 ALN HPN 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 R sorafenib tablets 64 mGluR2 NAM 64 alpha folate receptor 64 selective serotonin 2C receptor 64 potently inhibit 64 M2 subunit 64 NS3 protease 64 cortisol synthesis 64 inhibits Akt activation 64 Shigatoxin producing E. coli 64 peptide CGRP 64 Protease inhibitors 64 JAK#/JAK# 64 folate analogue metabolic 64 lintuzumab SGN 64 dasatinib Sprycel 64 HGS ETR1 mapatumumab 64 oral dihydropyrimidine dehydrogenase DPD 64 volociximab 63 beta 1a 63 Interferon beta 63 Valproic acid 63 triggers apoptosis 63 SinuNase TM 63 oral picoplatin 63 systemic anaplastic large 63 inhaled formulation 63 antiangiogenesis therapies 63 anionic backbone 63 bevacizumab Avastin ® 63 TELINTRA R 63 selective orally bioavailable 63 CDK inhibitor 63 prokinetic agent 63 IMiDs 63 thalidomide Thalomid 63 pan HDAC inhibitor 63 sarcoma melanoma 63 acyclovir Lauriad R 63 refractory chronic lymphocytic 63 R lenalidomide 63 EGFR HER2 63 selective modulator 63 ALVESCO ® 63 Protein Kinase C 63 XP# XP# 63 antisense inhibitors 63 molecule epidermal 63 LymphoStat B belimumab 63 mda 7 63 vascular disrupting agent 63 Zorbtive TM 63 receptor inhibitors 63 matrix metalloproteases 63 anti amnesic 63 investigational pharmacologically unique 63 Maribavir 63 selective inhibition 63 IMiDs ® 63 IMiDs ® compound 63 ® lenalidomide 63 SGLT2 inhibitors 63 SERMs 63 GVAX ® 63 Preclinical studies suggest 63 nab rapamycin 63 NMDA antagonist 63 Amgen Neulasta R 63 LHRH receptor positive 63 including eniluracil ADH 63 small molecule Hedgehog 63 5 FU leucovorin 63 pralatrexate injection folate analogue 63 non porcine pancreatic 63 Wafer polifeprosan 63 bevacizumab Avastin R 63 protein tyrosine phosphatase 1B 63 Talabostat 63 Solazed TM 63 phosphatidylinositol 3 63 compound PMX # 63 CRTH2 63 Cannabinor 63 opioid receptor antagonist 63 antiproliferative effects 63 c myc gene 63 Aflibercept 63 pan histone deacetylase 63 direct thrombin inhibitors 63 myeloproliferative disorders 63 generation purine nucleoside 63 Pruvel ™ 63 Zoraxel TM 63 inverse agonist 63 Vidaza ® 63 pathophysiological effects 63 delivers fluocinolone acetonide FA 63 ara C 63 Eculizumab 63 taxane resistant 63 DP VPA 63 MKC# MKC# PP 63 Angiotensin Converting Enzyme 63 novel emulsion formulation 63 Nektar proprietary 63 Tumor necrosis factor 63 PKC inhibitor 63 oral isotype selective HDAC 63 humanised monoclonal antibody 63 histone deacetylation 63 metastatic bladder 63 mGluR5 negative 63 thiazolides 63 diarrhea predominant irritable 63 albumin bound paclitaxel 62 small molecule defensin 62 Ad5FGF 4 62 psoriasis rheumatoid arthritis 62 HuLuc# 62 oral proteasome inhibitor 62 oral anti arrhythmic 62 Cytotoxic 62 Kinase Inhibitor 62 selective A2A adenosine receptor 62 MEK inhibitors 62 JUVISTA R Human 62 TLR9 agonist 62 alvespimycin 62 HGS# 62 sulfonylhydrazine class 62 factor Xa 62 intranasal formulation 62 PEGylated anti 62 DURECT proprietary 62 cathepsins 62 epithelial tumors 62 PORxin TM 62 5 HT6 receptor 62 CTAP# Capsules 62 triciribine phosphate monohydrate 62 Tyrosine Kinase Inhibitor 62 lenalidomide dexamethasone 62 FUSILEV enhances 62 induce apoptosis 62 Initiates Enrollment 62 Epothilones 62 CEA CD# Her2 62 hepatotoxic 62 cetuximab Erbitux R 62 androgen receptor AR 62 TPI ASM8 62 Transdrug R 62 Ovitrelle R Serostim 62 HCV RNA polymerase 62 Factor VIIa 62 RhuDex TM 62 compound AEZS 62 trial evaluating PRX# 62 AKT inhibitor 62 Raf kinase 62 microtubule inhibitor 62 IMA# 62 Carfilzomib 62 candidate DB# 62 Anidulafungin 62 Liposomal 62 oral candidiasis 62 Pathway Inhibitor 62 Leukine ® 62 inhibitor PPI 62 metaglidasen 62 novel immunomodulatory 62 RAF kinase 62 Archexin 62 novel histone deacetylase 62 Fc fusion protein 62 CYP#A# isoenzyme 62 RDEA# potent 62 p# mitogen activated 62 allosteric modulator NAM 62 novel orally administered 62 HQK 62 Ribavirin causes 62 NR2B selective 62 metastatic renal 62 chimeric monoclonal antibody 62 nilotinib Tasigna 62 MGd 62 Bruton tyrosine kinase 62 2A receptor agonist 62 Granulocyte Colony Stimulating Factor 62 NS5b 62 NS#/#A protease 62 TRO# 62 Enzastaurin 62 Romidepsin 62 non nucleoside 62 pancreatic prostate 62 MEK inhibitor 62 somatostatin analog 62 Janus Kinase 62 VEGFR2 inhibitor 62 c MET 62 humanized therapeutic 62 evaluating tivozanib 62 gefitinib Iressa 62 Myocet 62 systemically administered 62 Tumour Vascular Disrupting Agent 62 TTF Therapy 62 peripherally restricted 62 thetreatment 62 Janus kinase 62 Smac mimetics 62 oncolytic virus therapies 62 GRNOPC1 contains 62 V#F mutation 62 RhuDex ® 62 Methylnaltrexone 62 Locked Nucleic Acid 62 small molecule glucokinase 62 multitargeted 62 small molecule activator 62 potent inhibitor 62 toenail onychomycosis 62 5alpha reductase 62 PRT# 62 Microplasmin 62 Etoposide 62 negative allosteric modulator 62 Ph + acute lymphoblastic 62 Angiotensin converting enzyme 62 Viprovex R 62 thyroid hormone receptor 62 potassium binder 62 novel peptide 62 topically applied SEPA 62 cytokine signaling 62 AERx R 62 Omacetaxine 62 DG# compounds targeting 62 treat chronic rhinosinusitis 62 fosbretabulin 62 acadesine 62 Immunotherapeutic 62 carbohydrate polymer 62 hypervascular tumors 62 vinorelbine tartrate 62 TNF á 62 either acutely decompensated 62 DNA methyltransferase inhibitors 62 apoptosis inducers 62 Nexavar ® 62 Irinotecan 62 Potassium Chloride Sodium Ascorbate 62 humanized monoclonal antibodies 62 docetaxel Taxotere R 62 vascular disrupting agents 62 dihydrofolate reductase DHFR 62 MDS MPD 62 vaccines oncolytic virus 62 Blinatumomab 62 Angiotensin II 62 endothelin receptor 62 injectable investigational 62 molecular chaperone regulator 62 activin receptor type 62 OMP #M# 62 Factor VEGF 62 treat benign prostatic 62 dihydrochloride 61 ALN TTR 61 platform HDL Mimetic 61 TELINTRA 61 benzimidazole 61 tumor xenograft models 61 PPAR agonist 61 CB2 selective receptor agonist 61 INSPIRE Trial Phase III 61 sorafenib tablets 61 mTOR kinase 61 ribonucleotide reductase clinically validated 61 leukocyte adhesion 61 Panzem R NCD 61 siRNA binds 61 mild vasodilator 61 Denufosol 61 induces apoptosis 61 xenograft models 61 stable nucleic acid 61 PDX pralatrexate 61 selectively inhibits 61 hyaluronidase enzyme 61 antifolates 61 Azacitidine 61 cholesteryl ester transfer 61 VEGF inhibitors 61 docetaxel Taxotere ® 61 Flt3 61 Sphingomab TM 61 TRIOLEX HE# APOPTONE HE# 61 interferon alpha IFN 61 HCV protease 61 norepinephrine reuptake inhibitor 61 NuMimetic TM 61 peptidic compound 61 BRAF inhibitor 61 polyglutamate 61 histone deacetylase 61 TNFerade ™ 61 N methyl 61 Provecta TM 61 mocetinostat MGCD# 61 humanized anti 61 selectively inhibit 61 Certolizumab pegol 61 alpha 2A 61 metastatic malignant 61 refractory NSCLC 61 Phase Ib clinical trials 61 ErbB3 HER3 61 Teriflunomide 61 Panzem NCD 61 Fludara ® 61 FGFR3 61 CEQ# 61 Epstein Barr Virus EBV 61 albiglutide 61 PKC# 61 Hypoxia Inducible Factor 61 Angiotensin 61 LHRH antagonists 61 Temsirolimus 61 Zemiva TM 61 Trabectedin 61 Aptocine 61 serine threonine 61 aneurysms AAA 61 #HT# 61 reslizumab 61 Kit CD# positive 61 investigational HCV polymerase 61 somatostatin analogue 61 CD# monoclonal antibody 61 PSN# [001] 61 insulin sensitizer 61 vesicular monoamine transporter 61 IgG1 monoclonal antibody 61 ERK1 2 61 Tyrima 61 pertuzumab 61 mTOR inhibitor 61 recurrent glioblastoma multiforme 61 Commonly prescribed 61 CCR9 antagonist 61 Pertuzumab 61 potent inducer 61 antimetabolite 61 oral Factor Xa 61 HIF PH 61 sodium glucose transporter 61 pharmacokinetic interactions 61 pimozide 61 delta isoform 61 Lenocta TM sodium stibogluconate 61 luteinizing hormone releasing 61 Thiovir 61 plus prednisone prednisolone 61 Shows Statistically Significant 61 Interferon gamma 61 non splenectomized 61 monoclonal antibody IgG1 Mab 61 Orally administered 61 sorafenib Nexavar 61 TOCOSOL 61 PI3K/Akt pathway inhibitor 61 gamma secretase inhibitor 61 R bisoprolol Euthyrox 61 Arsenic trioxide 61 potent antiproliferative 61 cyclophilin inhibitors 61 poly ADP ribose polymerase 61 generation Hsp# inhibitor 61 ocular formulation 61 selective adhesion molecule 61 retinoic acid receptor 61 trastuzumab Herceptin R 61 alpha adrenergic 61 alpha TNFa 61 anticancer therapeutics 61 chronic thromboembolic pulmonary 61 certain protein tyrosine 61 antiangiogenesis 61 corticosteroid dexamethasone 61 lexidronam injection 61 CDK cyclin dependent 61 potently inhibits 61 Factor Xa 61 immuno modulatory 61 glucagon receptor 61 5 HT1A 61 novel antiviral therapeutics 61 Glucocorticoids 61 Cobalamin TM mediated 61 Veronate R 61 HGS ETR2 61 treats acute lymphoblastic 61 adenosine A2A 61 neuropathic pain metabolic diseases 61 orally bioavailable 61 ABLYNX 61 Presents Preclinical Data 61 novel L DOS# 61 cell lymphoma CTCL 61 DNAi 61 sapacitabine CYC# 61 Zalypsis 61 pediatric malignancies 61 receptor CXCR4 61 tyrosine kinase inhibitor 61 lenalidomide Revlimid R 61 AERx ® 61 chronic idiopathic thrombocytopenic purpura 61 pathological hallmarks 61 Vascular Disrupting Agent 61 Degarelix 61 candidate XP# 61 OMP #R# 61 angiotensin receptor 61 cytostatic 61 JAK1 61 visilizumab 61 gemcitabine Gemzar 61 Seliciclib 61 Serostim R 61 Oragens TM 61 GEM OS2 61 RAS MAPK pathway 61 PDGF receptor 61 c Raf kinase 61 chronic myocardial ischemia 61 Cloretazine VNP#M 61 Plecanatide 61 adenosine receptor 61 catheter occlusion 61 compound perifosine 61 dihydro 61 Leukopenia neutropenia 61 VEGF receptors 61 inflammatory PDE 61 BiovaxID TM 61 Vidaza R 61 Lisofylline 61 cytotoxic T lymphocyte 61 M1 muscarinic 61 ERK pathway 61 EOquin TM phase 61 Dalbavancin 61 Chemokine Receptor 61 alkylating 61 5 HT1A receptor 61 torsade de pointes 61 Homspera TM 60 Pegylated 60 oral Janus kinase 60 oxidative stress inducer 60 polymerase inhibitor 60 Epratuzumab 60 HDAC Inhibitor 60 5 fluorouracil leucovorin 60 ERK5 60 DOS# 60 NMDA N 60 microtubule dynamics 60 Vicinium TM 60 treating neuropathic pain 60 Cytochrome P# 60 class mGluR5 inhibitor 60 antineoplastic 60 vaginal candidiasis 60 methylnaltrexone bromide 60 product candidate Lpathomab 60 Iluvien ® 60 FGFR 60 carmustine 60 delay bone metastases 60 small molecule activators 60 JAK inhibitor 60 monoclonal antibody MAb 60 erlotinib Tarceva R 60 bucindolol hydrochloride 60 Drug Candidate 60 defensin mimetic antibiotic 60 tiapamil 60 headache nasopharyngitis 60 mesylate 60 Dasatinib 60 novel synthetic peptide 60 Thiarabine 60 p# alpha [001] 60 MEK1 60 Zemiva ™ 60 cyclin dependent kinases CDKs 60 thromboxane A2 60 anticancer compound 60 rusalatide acetate 60 Panzem ® 60 targetters 60 Exelixis compounds 60 NKG2D 60 Endologix Powerlink System 60 mTOR inhibitors 60 GA GCB 60 long acting muscarinic 60 SPRYCEL ® 60 orally bioavailable mimics 60 tiagabine 60 cell adhesion molecule 60 TLK# 60 Tykerb lapatinib 60 skeletal metastases 60 JAK2 inhibitor 60 Symadex 60 LPA1 receptor 60 effector function 60 selective agonist 60 humanized monoclonal antibody 60 OvaRex R 60 somatropin Kuvan R 60 5 HT3 antagonist 60 pharmacological chaperone 60 benign prostatic hypertrophy BPH 60 selective antagonists 60 chemokine receptor 60 phosphate S1P 60 IMPDH inhibitor 60 VALSTAR TM 60 virus HCV protease inhibitor 60 thrombin receptor 60 BRAF mutant 60 fibrotic disease 60 selective estrogen receptor modulator 60 Interferon alpha 60 p# MAP kinase inhibitor 60 personalized cellular immunotherapy 60 lung pancreatic 60 factor TNF 60 IGF1R 60 Ostabolin C TM 60 active cellular immunotherapies 60 develop HBV reactivation 60 muscarinic receptor agonist 60 Allovectin 7 60 candidate Zemiva TM 60 bortezomib Velcade 60 Methotrexate MTX 60 Initiates Clinical Trial 60 TELCYTA R 60 Lixivaptan 60 taxane derivative 60 subependymal giant cell 60 potent inhibitors 60 synthase TS 60 demethylating agent 60 ASONEP TM 60 DCVax R 60 Onconase 60 nucleotide analogue 60 transthyretin TTR mediated amyloidosis 60 serotonin reuptake 60 Parkinson disease levodopa induced 60 anti PlGF 60 HDAC enzymes 60 receptor antagonists 60 IAP inhibitors 60 receptor inhibitor 60 Inhalation Powder 60 AFREZZA TM 60 mGluR5 NAM 60 investigational oral inhibitor 60 #HT#A 60 receptor modulators 60 reverse transcriptase inhibitors 60 LAB CGRP 60 sodium thiosulfate STS 60 fibrin deposition 60 monoclonal antibody conjugated 60 rxRNA 60 Sapacitabine 60 HCD# [002] 60 immunotherapeutic agent 60 orally inhaled migraine 60 Angiocept 60 Aviptadil 60 imatinib resistant 60 systemic fungal infections 60 Pagoclone 60 adrenoceptor agonist 60 Vidaza azacitidine 60 Olaparib 60 Onalta ™ 60 EVIZON TM 60 Romiplostim 60 antibody MAb 60 sulindac 60 Provectus Pharmaceuticals specializes 60 Raf MEK ERK 60 hypoxia inducible factor 60 castration resistant hormone refractory 60 TO AVOID PREGNANCY WHILE 60 agonistic human 60 somatostatin 60 factor HGF 60 Files IND 60 PROSTASCINT R 60 p# MAPK 60 echinocandin 60 ErbB1 60 immunomodulatory therapy 60 XL# inhibits 60 SPL# Gel vaginal microbicide 60 novel proprietary KL4 60 uricase 60 HuMax 60 targeting PCSK9 60 next generation URAT1 60 proprietary polysaccharide 60 Crizotinib PF # 60 gemcitabine Gemzar ® 60 triple VEGF receptor 60 CA4P 60 H2 antagonists 60 anti angiogenic agent 60 enzyme inhibitor 60 Akt inhibitor 60 interleukin IL -# 60 targeting CD# 60 FOLOTYN ® 60 inhibit oxidative stress 60 Fingolimod 60 immune modulating 60 Myolimus 60 alpha1 antitrypsin deficiency 60 tumor lysis syndrome 60 delipidation 60 Luteinizing Hormone Releasing Hormone 60 alkylating agents 60 inhibit vascular endothelial 60 5 HT3 receptor 60 YONDELIS 60 acute peripheral arterial 60 metastatic gastric 60 Recombinant Human 60 4 PDE4 enzyme 60 GI GVHD common 60 thiazolidinedione TZD 60 ALK inhibitors 60 CYP #A# 60 product platforms AZX# 60 Pimavanserin 60 cytotoxic effects 60 refractory cutaneous T 60 orally dosed 60 Antiarrhythmic 60 selective phosphodiesterase 60 Silodosin 60 inhibits protein synthesis 60 prodrugs 60 metabolic disorders Saizen R 60 Onalta TM 60 investigational monoclonal antibody 60 Intermezzo ® zolpidem tartrate 60 mediated inhibition 60 Kamada AAT 60 isoenzyme 59 antisense inhibitor 59 antibody MT# 59 Delta opioid receptor 59 therapeutically inactive prodrug 59 pancreatic endocrine 59 Amgen Neulasta ® 59 efaproxiral 59 covalently bound 59 complement inhibitor eculizumab 59 specific CCR9 antagonist 59 CD4 monoclonal antibody 59 Completes Patient Enrollment 59 prokinetic 59 PPAR gamma agonist 59 Vascugel 59 p# inhibitor 59 TAFA# 59 Overexpression 59 prostaglandin D2 59 #beta HSD 1 59 Shows Promise Against 59 Ganciclovir 59 Itraconazole 59 SGLT 2 59 Trastuzumab DM1 59 HER2 ErbB2 59 protein receptors lectins 59 cytoprotective 59 Cyclosert TM 59 tubulin binding 59 PEGylated interferon beta 1a 59 anti botulism antibody 59 Akt activation 59 ATL# [002] 59 VA# [002] 59 murine model 59 Epothilone D 59 neuropathic pain spasticity 59 intravesical instillation 59 primidone 59 Avanafil 59 VAPRISOL 59 engineered anticoagulant 59 severe gastroparesis 59 potent triglyceride lowering 59 reverse transcriptase inhibitor 59 TRAIL receptor antibodies 59 hypertrichosis occurred 59 fumarate 59 EGFr humanized monoclonal antibody 59 potent inhibition 59 antifibrotic 59 conventional DMARDs 59 IGF IR 59 Curaxin CBLC# 59 neuronal nicotinic receptor NNR 59 factor VIIa 59 TNF α 59 S1P antibody 59 progressive metastatic prostate 59 lapatinib Tykerb 59 LymphoStat B TM 59 nonhematologic adverse reactions 59 Inhalation Solution 59 targeting miR 59 Pradefovir 59 oral anticoagulant agent 59 teriflunomide 59 potent topoisomerase II 59 immune modulator 59 C1 INH deficiency 59 Tramiprosate ALZHEMED TM 59 PrevOnco 59 novel cardiac myosin 59 DIFICID ™ 59 monoamine oxidase inhibitors 59 GMX# 59 aldehyde dehydrogenase ALDH2 deficiency 59 MKC# 59 cardio metabolic diseases 59 SARMs 59 adriamycin 59 Bezielle 59 dihydrofolate reductase 59 mecamylamine 59 erlotinib Tarceva 59 XmAb ™ 59 drug ISA# 59 Neulasta R 59 PDE# inhibitors 59 PEGylated interferon 59 Oral Fingolimod 59 plasma kallikrein inhibitor 59 ALN PCS 59 HepDirect R 59 ZEVALIN ® 59 anti infective treatments 59 Adenoscan R 59 TKB# 59 polymer conjugate technology 59 tyrosine kinase receptor 59 cytolytic 59 AdhTAP 59 related apoptosis inducing 59 gastrointestinal stromal tumors GIST 59 hapten 59 Glioblastoma multiforme GBM 59 anti angiogenic 59 octreotide acetate 59 HCV polymerase 59 pemphigus vulgaris 59 inhibit angiogenesis 59 mutated p# 59 cardiotoxic 59 Achieves Primary Endpoint 59 using Innocoll proprietary 59 BRAF kinase 59 imatinib Gleevec 59 peptibody 59 Sezary syndrome 59 COPEGUS R 59 lymphoid tumors 59 CD# expressing 59 R bendamustine hydrochloride 59 NMDA antagonists 59 hydroxypropyl 59 Atripla combines 59 syngeneic 59 Ceflatonin R 59 Fibroblast Growth Factor Receptor 59 Dapagliflozin 59 specific lectin receptors 59 Crofelemer budesonide foam 59 lysosomal storage disorder 59 novel immunotherapies 59 converting enzyme 59 Aclidinium 59 methyl D aspartate 59 type glutamate receptor 59 Aeolus Pharmaceuticals Announces 59 phase III isavuconazole 59 aripiprazole Abilify 59 superficial bladder cancer 59 oral ghrelin agonist 59 GSK# [002] 59 Iloperidone 59 alpha interferons 59 anticancer activity 59 oncolytic 59 Tasigna prolongs